Systematic Growth, which owns Wellma Group AB, is weighing a possible exit from the business, according to people briefed on the discussions who requested anonymity because the talks are private. The investment firm has brought in an adviser as it evaluates a potential divestment. Systematic Growth's spokesperson declined to comment.
According to those people, initial expectations point to a sale price topping €1 billion ($1.1 billion) for Wellma. A launch of the sale process is anticipated in October. The process remains in its infancy, and the firm may decide to retain the asset instead of moving ahead with a sale.
Wellma is a Stockholm-based contract developer and manufacturer serving wellness brands with food supplements, nutraceuticals and pharmaceuticals. Its website lists 15 production sites, coverage in more than 50 markets worldwide, and a catalog of over 5,000 formulations.
Big corporate changes can remind investors to review how they protect and grow savings. Join Briefs Finance CEO Jaspreet Singh on September 29th for a FREE live investor workshop, How to Profit From A Dollar That's Losing its Value, where he shows how we're spotting investment opportunities as the dollar falls. Save your spot.
If a sale proceeds, ownership of a sizable contract manufacturer with global reach and a deep product library would change hands, which can ripple through customer relationships, pricing and capacity. The key dates to watch: whether a process actually launches in October and any on-the-record updates from Systematic Growth, which has so far declined to comment.
When business ownership shifts, steady strategies help keep your long term goals intact. Our CEO Jaspreet Singh is hosting a FREE live investor workshop, How to Profit From A Dollar That's Losing its Value, on September 29th. Sign up free to join him live.
